Waters Corporation has co-led a round that took bioanalytical technology producer Redshift Bioanalytics' total funding to $35m since 2005.

Microsoft Ventures has contributed to a round featuring all Livongo's existing investors, which include Merck, Wanxiang and Blue Cross Blue Shield of Massachusetts.

The property developer has backed the $300m first fund for Pivotal BioVenture Partners, a biotech venture firm formed by an ex-Roche Venture Fund investment director.

The dermatology product maker has invested in five digital health startups through its Leo Innovation Lab subsidiary.

Innovation Network Corporation of Japan has joined forces with Takeda Pharmaceutical and Medipal Holdings to set up Scohia Pharma with an initial $87m in funding.

The healthcare provider has formed a corporate venturing subsidiary called Spectrum Health Ventures and will invest up to $100m in the next 10 years.

The ex-GV chief executive is reportedly set to close his $100m Section 32 fund in the next few weeks and will be the entity's sole investing partner.

Royal Philips and the Singaporean state-owned EDBI will accelerate a digital health investment partnership that has just made its first deal.